Q1 2020 Results Slides

Issue link: https://liminalbiosciences.com/resources/i/1247103

Contents of this Issue


Page 8 of 11

© 2020 Liminal BioSciences Inc. Financial Position at March 31, 2020 9 Funds available Working capital: $41.1M Line of credit: $29.1M Potential sources of funding Strategic collaborations Monetize non-core assets Issuance of equity Grant funding Extend Cash runway

Articles in this issue

view archives of Webcasts - Q1 2020 Results Slides